A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Published:2021-03-25 Issue:12 Volume:384 Page:1113-1124
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Newsome Philip N.¹,Buchholtz Kristine¹,Cusi Kenneth¹,Linder Martin¹,Okanoue Takeshi¹,Ratziu Vlad¹,Sanyal Arun J.¹,Sejling Anne-Sophie¹,Harrison Stephen A.¹

Affiliation:

1. From the National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, and the Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham (P.N.N.), and the Radcliffe Department of Medicine, University of Oxford, Oxford (S.A.H.) — all in the United Kingdom; Novo Nordisk, Søborg, Denmark (K.B., M.L., A.-S.S...

Funder

Novo Nordisk A/S

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2028395

Cited by 1044 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice;Molecular Metabolism;2024-11

3. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

4. Clinical Efficacy and Body Composition Changes with Sodium Glucose Cotransporter 2 Inhibitor/Glucagon-like Peptide-1 Antagonist Combination Therapy in Patients with Type 2 Diabetes Mellitus-associated Nonalcoholic Fatty Liver Disease;Internal Medicine;2024-09-15

5. The relationship between diabetes mellitus and non-alcoholic fatty liver disease: a clinical and instrumental paired study;Terapevticheskii arkhiv;2024-09-14